Chiasma Company Profile (NASDAQ:CHMA)

About Chiasma

Chiasma logoChiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion. The Company is developing octreotide capsules as a liquid-filled solid gelatin capsule formulation, which is intended to be taken over twice a day. The Company's TPE technology enhances the absorption through the intestinal wall of drugs. The Company also focuses on developing CH2 for Orphan indication.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CHMA
  • CUSIP:
Key Metrics:
  • Previous Close: $1.80
  • 50 Day Moving Average: $1.92
  • 200 Day Moving Average: $2.33
  • 52-Week Range: $1.55 - $13.38
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.00
  • P/E Growth: 0.00
  • Market Cap: $43.85M
  • Outstanding Shares: 24,359,000
  • Beta: 1.72
Profitability:
  • Return on Equity: -51.99%
  • Return on Assets: -46.38%
Debt:
  • Current Ratio: 11.80%
  • Quick Ratio: 11.80%
Additional Links:
Companies Related to Chiasma:

Analyst Ratings

Consensus Ratings for Chiasma (NASDAQ:CHMA) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $15.50 (761.11% upside)

Analysts' Ratings History for Chiasma (NASDAQ:CHMA)
Show:
DateFirmActionRatingPrice TargetDetails
1/17/2017Barclays PLCDowngradeEqual Weight -> UnderweightView Rating Details
5/13/2016Cowen and CompanyReiterated RatingHoldView Rating Details
4/18/2016Oppenheimer Holdings, Inc.Reiterated RatingOutperform$43.00 -> $9.00View Rating Details
4/18/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Chiasma (NASDAQ:CHMA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
8/10/2016Q2($0.63)($1.10)ViewListenView Earnings Details
5/11/2016Q1($0.63)($0.71)ViewListenView Earnings Details
3/14/2016Q4($0.53)($0.61)ViewListenView Earnings Details
11/12/2015Q315($0.38)($0.46)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chiasma (NASDAQ:CHMA)
Current Year EPS Consensus Estimate: $-2.56 EPS
Next Year EPS Consensus Estimate: $-0.90 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.70)($0.52)($0.61)
Q2 20162($0.78)($0.75)($0.77)
Q3 20162($0.90)($0.83)($0.87)
Q4 20162($0.93)($0.52)($0.73)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Chiasma (NASDAQ:CHMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Chiasma (NASDAQ:CHMA)
Insider Ownership Percentage: 3.20%
Institutional Ownership Percentage: 58.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/21/2015Health Ventures Lp 7-MedMajor ShareholderBuy93,750$16.00$1,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Chiasma (NASDAQ:CHMA)
DateHeadline
News IconTrading Radar: Checking Technicals for Chiasma Inc (CHMA) - Rives Journal (NASDAQ:CHMA)
rivesjournal.com - February 14 at 10:05 PM
News IconCompany Watch: Checking the Numbers on Shares of Chiasma Inc (CHMA) - Piedmont Register (NASDAQ:CHMA)
piedmontregister.com - February 9 at 2:36 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Chiasma, Inc. (NASDAQ:CHMA) - Nelson Research (NASDAQ:CHMA)
nelsonobserver.com - January 31 at 9:42 PM
News IconHoning in on Shares of Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 31 at 9:42 PM
News IconIs This Stock Capable of a Bull Run: Chiasma, Inc. (NASDAQ:CHMA) - Nelson Research (NASDAQ:CHMA)
nelsonobserver.com - January 30 at 10:09 PM
News IconRelative Strength Index Review on Shares of Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 30 at 10:09 PM
News IconWatching Technical Positions on Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 27 at 5:39 PM
News IconTrading Spotlight: Zooming in on Shares of Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 26 at 5:15 PM
News IconEarnings in Full Force, Analysts Take Aim at Chiasma Inc (NASDAQ:CHMA) - Wall Street Beacon (NASDAQ:CHMA)
wsbeacon.com - January 26 at 5:15 PM
News IconLooking at Moving Averages for Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 24 at 4:51 PM
News IconTicker Watch: Technical Views on Shares of Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 24 at 4:51 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Chiasma, Inc. (NASDAQ:CHMA) - Wall Street Beacon (NASDAQ:CHMA)
wsbeacon.com - January 21 at 9:26 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Chiasma Inc (NASDAQ:CHMA) - Aiken Advocate (NASDAQ:CHMA)
aikenadvocate.com - January 20 at 10:28 PM
News IconWhat are the Levels Indicating for This Stock: Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 19 at 5:29 PM
News IconTrading Watch: ADX and CCI Review for Chiasma Inc (CHMA) - Sherwood Daily (NASDAQ:CHMA)
sherwooddaily.com - January 19 at 2:39 AM
News IconDetails of Barclays Underweight Rating on Chiasma Inc (CHMA) - Highland Mirror (NASDAQ:CHMA)
www.highlandmirror.com - January 19 at 2:39 AM
finance.yahoo.com logoChiasma downgraded by Barclays (NASDAQ:CHMA)
finance.yahoo.com - January 17 at 5:04 PM
News IconRating Sentiment Coverage: It's been a crucial week for Chiasma Inc (NASDAQ:CHMA); here's what analysts have to say. - Fair View Times (NASDAQ:CHMA)
fairviewtimes.com - January 13 at 10:02 PM
News IconIs There a Catalyst Out There For Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 13 at 10:02 PM
News IconWill The Needle Move For Chiasma Inc (NASDAQ:CHMA) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:CHMA)
wsbeacon.com - January 13 at 5:00 PM
News IconPrice Action To Observe: Could Chiasma Inc See a Reversal After This Very Strong Session? - Fair View Times (NASDAQ:CHMA)
fairviewtimes.com - January 13 at 5:00 PM
News IconPeering into Recent Action from Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 13 at 5:00 PM
News IconStock Reaching Most Volatile List Today: Chiasma, Inc. (NASDAQ:CHMA) - Wall Street Beacon (NASDAQ:CHMA)
wsbeacon.com - January 12 at 2:46 AM
News IconIs this Stock Under $5 a Bargain: Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 11 at 4:41 PM
News IconIs the Needle Ready to Move for Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 11 at 3:03 AM
us.rd.yahoo.com logoChiasma Provides Year-End Corporate Update and Preliminary Outlook for 2017 (NASDAQ:CHMA)
us.rd.yahoo.com - January 9 at 5:25 PM
us.rd.yahoo.com logo8:14 am Chiasma reviews 2016, provides preliminary outlook for 2017 (NASDAQ:CHMA)
us.rd.yahoo.com - January 9 at 5:25 PM
biz.yahoo.com logoCHIASMA, INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an (NASDAQ:CHMA)
biz.yahoo.com - January 9 at 5:25 PM
News IconA Keen Look at These Shares: Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 6 at 9:41 PM
News IconChiasma (CHMA) Shares March Higher, Can It Continue? - Yahoo News (NASDAQ:CHMA)
www.yahoo.com - January 6 at 9:41 PM
finance.yahoo.com logoChiasma (CHMA) Shares March Higher, Can It Continue? (NASDAQ:CHMA)
finance.yahoo.com - January 6 at 4:41 PM
News IconIgniting Curiosity on This Name, Investor Update on Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 5 at 6:20 AM
News IconInvestors Swarm in on Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - January 3 at 6:01 PM
finance.yahoo.com logo3:16 pm Chiasma: FDA states that Octreotide capsules are misbranded; requests Chiasma submit written response letter by January 6 (NASDAQ:CHMA)
finance.yahoo.com - December 27 at 4:33 PM
capitalcube.com logoChiasma, Inc. :CHMA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 23, 2016 (NASDAQ:CHMA)
www.capitalcube.com - December 23 at 4:27 PM
capitalcube.com logoChiasma, Inc. :CHMA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 23, 2016 (NASDAQ:CHMA)
www.capitalcube.com - December 23 at 4:27 PM
News IconStreetwise Investors Taking Note of Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - December 22 at 9:25 PM
News IconStock Vacillating Higher Pre-Bell: Chiasma, Inc. (NASDAQ:CHMA) - Prospect Journal (NASDAQ:CHMA)
prospectjournal.com - December 20 at 7:52 AM
News IconTraders are Keeping Track of Technicals on Shares of Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 25 at 4:17 PM
News IconPenny Stock Spotlight: Focusing on Chiasma, Inc. (NASDAQ:CHMA) - Duncan Research (NASDAQ:CHMA)
www.duncanindependent.com - November 24 at 4:16 PM
News IconTrend Strength Monitor on Shares of Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 24 at 4:16 PM
News IconTechnical Investor Update on Shares of Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 21 at 10:15 PM
News IconPenny Stock Making Waves: Investors Keen on Chiasma, Inc. (NASDAQ:CHMA) - Duncan Research (NASDAQ:CHMA)
www.duncanindependent.com - November 21 at 10:15 PM
News IconMA Watch on Shares of Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 20 at 8:19 AM
News IconRSI, CCI, and ADX Levels in View for Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 18 at 8:32 PM
News IconPenny Stock Focus: Narrowing the Lens On Chiasma, Inc. (NASDAQ:CHMA) - Duncan Research (NASDAQ:CHMA)
www.duncanindependent.com - November 18 at 8:32 PM
News IconTrading Activity in Focus for Chiasma Inc (CHMA) - MicroCap Wired (NASDAQ:CHMA)
www.microcapwired.com - November 17 at 3:25 PM
finance.yahoo.com logoCHIASMA, INC Financials (NASDAQ:CHMA)
finance.yahoo.com - November 17 at 3:25 PM
News IconMy Watchlist for Thursday, November 17 (NASDAQ:CHMA)
ac-investor.blogspot.com - November 17 at 11:39 AM
News IconUpdate on Valuation Formula's For Chiasma, Inc. (NASDAQ:CHMA) - Wall Street Lion (NASDAQ:CHMA)
wslnews.com - November 16 at 9:53 PM

Social

What is Chiasma's stock symbol?

Chiasma trades on the NASDAQ under the ticker symbol "CHMA."

Where is Chiasma's stock going? Where will Chiasma's stock price be in 2017?

4 brokers have issued 1 year price objectives for Chiasma's stock. Their forecasts range from $5.50 to $32.00. On average, they anticipate Chiasma's share price to reach $15.50 in the next year.

When will Chiasma announce their earnings?

Chiasma is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

What are analysts saying about Chiasma stock?

Here are some recent quotes from research analysts about Chiasma stock:

  • According to Zacks Investment Research, "Chiasma, Inc. is a biopharmaceutical company. The company's TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA. " (1/17/2017)

  • Cowen and Company analysts commented, "The main focus of CHMA’s Q1 update was the status of talks with FDA regarding." (5/13/2016)

Who owns Chiasma stock?

Chiasma's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (13.09%).

Who bought Chiasma stock? Who is buying Chiasma stock?

Chiasma's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC.

How do I buy Chiasma stock?

Shares of Chiasma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Chiasma stock cost?

One share of Chiasma stock can currently be purchased for approximately $1.80.

Chiasma (NASDAQ:CHMA) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Chiasma (NASDAQ:CHMA)

Earnings History Chart

Earnings by Quarter for Chiasma (NASDAQ:CHMA)

Dividend History Chart

Dividend Payments by Quarter for Chiasma (NASDAQ:CHMA)

Last Updated on 2/20/2017 by MarketBeat.com Staff